Schwartz Investment Counsel’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,846
Closed -$249K 139
2023
Q2
$249K Hold
1,846
0.01% 133
2023
Q1
$294K Hold
1,846
0.01% 131
2022
Q4
$298K Hold
1,846
0.01% 127
2022
Q3
$248K Sell
1,846
-278
-13% -$39.9K 0.01% 126
2022
Q2
$325K Hold
2,124
0.02% 121
2022
Q1
$344K Hold
2,124
0.01% 121
2021
Q4
$288K Hold
2,124
0.01% 131
2021
Q3
$229K Hold
2,124
0.01% 128
2021
Q2
$239K Hold
2,124
0.01% 128
2021
Q1
$230K Hold
2,124
0.01% 128
2020
Q4
$228K Buy
+2,124
New +$204K 0.01% 126
2020
Q3
Sell
-2,224
Closed -$218K 129
2020
Q2
$218K Buy
+2,224
New +$196K 0.01% 124
2020
Q1
Sell
-2,400
Closed -$212K 115
2019
Q4
$212K Buy
+2,400
New +$199K 0.01% 120
2019
Q1
Sell
-2,400
Closed -$221K 122
2018
Q4
$221K Hold
2,400
0.01% 125
2018
Q3
$227K Hold
2,400
0.01% 130
2018
Q2
$222K Hold
2,400
0.01% 128
2018
Q1
$227K Hold
2,400
0.01% 125
2017
Q4
$232K Hold
2,400
0.01% 120
2017
Q3
$213K Buy
+2,400
New +$183K 0.01% 119
2014
Q1
Sell
-61,805
Closed -$3.26M 181
2013
Q4
$3.26M Hold
61,805
0.24% 97
2013
Q3
$2.77M Hold
61,805
0.24% 101
2013
Q2
$2.56M Buy
+61,805
New +$2.7M 0.25% 101

Other funds holding ABBV

Schwartz Investment Counsel's ABBV Position: Q3 2023 in Review

Schwartz Investment Counsel sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 1,846 shares — an estimated $249K sold.

Schwartz Investment Counsel first reported a position in ABBV in Q2 2013 and held it in 22 quarters. The position peaked at $3.26M in Q4 2013. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Schwartz Investment Counsel reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Schwartz Investment Counsel sold 1,846 AbbVie shares in Q3 2023, an estimated $249K.
  • Schwartz Investment Counsel first reported a position in AbbVie in Q2 2013 and held it in 22 quarters.
  • Schwartz Investment Counsel's AbbVie position peaked at $3.26M in Q4 2013.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Schwartz Investment Counsel's 13F filing for Q3 2023, filed 17 Oct 2023.